Clinical Trial Update: Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating itraconazole to prevent fungal infections in chronic granulomatous disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Drugs mentioned

• Itraconazole (Itraconazole)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Mycoses | Phase 2 | Status: COMPLETED